Circadian Rhythm and Metabolic Effects of Exercise
Launched by KAROLINSKA INSTITUTET · Nov 1, 2021
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
Exercise has well-established metabolic benefits and is a preferred intervention for Type 2 diabetes prevention and management. Metabolic determinants of exercise such as skeletal muscle and whole-body substrate oxidation capacity, glucose tolerance and insulin sensitivity and adipose tissue fatty acid release all show circadian oscillations. These rhythms may promote substantially different responses depending on the time of day when exercise is performed.
This is an exploratory study aiming to determine whether exercise at specific times of day can amplify the beneficial effects on glyce...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Body Mass Index (BMI): 23 - 33 kg/m2
- • Participants diagnosed with Type 2 Diabetes (insulin independent) or participants without Type 2 Diabetes (based on normal HbA1c and fasting glucose levels).
- • Ability to provide informed consent
- • Ability to complete the exercise regiment
- Exclusion Criteria:
- • Medications: Insulin
- • Current nicotine user (cigarettes, snus, nicotine gum) or past nicotine users less than 6 months before inclusion in the study
- • Pre-existing cardiovascular condition (Angina pectoris, Cardiac arrhythmia, Cardiac infarction, Coronary stent / angiography, Cerebrovascular insult, Hypertension \[\> 160 mmHg systolic, or \> 95 mmHg diastolic\])
- • Pre-existing blood-borne disease (HIV, Hepatitis C, MRSA)
- • Pre-existing systemic or localized rheumatic illness
- • Malignant Disease
- • Pre-existing psychiatric disorder
- • Another pre-existing systemic disease
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
Patients applied
Trial Officials
Harriet Wallberg-Henriksson, MD PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials